Product Description: SX-682 is an orally bioavailable, potent allosteric inhibitor of CXCR1 and CXCR2. SX-682 can block tumor myeloid-derived suppressor cells (MDSCs) recruitment and enhance T cell activation and antitumor immunity[1].
Applications: Cancer-programmed cell death
Formula: C19H14BF4N3O4S
References: [1]Sun L, et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 2019 Apr 4;4(7)./[2]Lu X, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017 Mar 30;543(7647):728-732.
CAS Number: 1648843-04-2
Molecular Weight: 467.20
Compound Purity: 99.67
Research Area: Cancer; Inflammation/Immunology; Endocrinology